Back to Compound Explorer

Hanabiratakelide

In vitro

Mechanism of Action

Hanabiratakelide is a resorcylic acid lactone unique to Sparassis crispa that inhibits the TAK1-mediated NF-κB activation pathway, suppressing downstream expression of pro-inflammatory mediators including TNF-α, IL-6, and COX-2. This mechanism targets an upstream kinase in the inflammatory cascade, providing broader anti-inflammatory coverage than direct COX inhibition alone.

Research Notes

Hanabiratakelide was isolated from S. crispa fruiting bodies by Yoshikawa et al. and demonstrated dose-dependent inhibition of NF-κB activation in cell-based reporter assays. Anti-inflammatory activity was confirmed through suppression of LPS-induced cytokine production in murine macrophages. The compound is considered a chemotaxonomic marker for Sparassis species. All evidence is in vitro.

Found In 1 Herb

3D Molecular Structure

Beta-resorcylic acid lactone
Drag to rotate · Click atoms to explore

Hanabiratakelide

Beta-resorcylic acid lactoneCyclic esters with diverse pharmacological activities

Representative pattern: C₂₁H₃₀O₂

Atoms
Carbon
Oxygen

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.